2015
DOI: 10.1016/j.jalz.2015.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2

Abstract: INTRODUCTION ADNI is now in its 10th year. The primary objective of the MRI core of ADNI has been to improve methods for clinical trials in Alzheimer’s disease and related disorders. METHODS We review the contributions of the MRI core from present and past cycles of ADNI (ADNI 1, GO and 2). We also review plans for the future – ADNI 3. RESULTS Contributions of the MRI core include creating standardized acquisition protocols and quality control methods; examining the effect of technical features of image ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
105
0
6

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
3

Relationship

5
4

Authors

Journals

citations
Cited by 162 publications
(115 citation statements)
references
References 176 publications
2
105
0
6
Order By: Relevance
“…The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing large-scale, multi-center, longitudinal study designed to improve methods for clinical trials by identifying brain imaging, clinical, cognitive, and molecular biomarkers of AD and aging. Now in its third phase (ADNI3), ADNI continues to incorporate newer technologies as they become established (Jack et al, 2015); data from ADNI, collected at participating sites across the U.S. and Canada, is publicly available and has been used in a diverse range of publications (Veitch et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing large-scale, multi-center, longitudinal study designed to improve methods for clinical trials by identifying brain imaging, clinical, cognitive, and molecular biomarkers of AD and aging. Now in its third phase (ADNI3), ADNI continues to incorporate newer technologies as they become established (Jack et al, 2015); data from ADNI, collected at participating sites across the U.S. and Canada, is publicly available and has been used in a diverse range of publications (Veitch et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…ADNI's second phase (ADNI2) introduced, to the initiative, the use of diffusion-weighted MRI (dMRI) as an additional approach for tracking AD progression (Jack et al, 2015). dMRI has since been used in numerous studies to understand the effects of AD on white matter (WM) microstructure and brain connectivity (Daianu et al, 2013a,b;Nir et al, 2013;Prasad et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…The three‐dimensional (3D) MPRAGE volumes were acquired with the following parameters: repetition time (TR)/inversion time (TI)/echo time (TE)/α/time to acquisition (TA) = 2300 ms/900 ms/2.86 ms/9°/5:20, echo spacing = 7 ms, matrix 256 × 256 × 176, 1.0 mm 3 isotropic, 2 × iPAT with 24 reference lines, Cartesian sampling scheme, closely resembling the updated ADNI protocol . The FIDnav acquisition module (α = 9°, 64 points in 0.2 ms, TI = 1532 ms) and the IMGnav module (gradient echo (GRE), α/TA = 9°/1.2 s, echo spacing = 7 ms, six echoes, matrix size 64 × 64 × 32, voxel size 4.1 × 4.1 × 6.0 mm 3 ) were added to a prototype MPRAGE sequence.…”
Section: Methodsmentioning
confidence: 99%
“…For comparison, all ADNI scans were reviewed by a quality control team at the Mayo clinic for issues such as protocol deviation or motion artifact (19), similar to what is being done within ON-DRI.…”
Section: Challenges Associated With Large Multi-site Imaging Studiesmentioning
confidence: 99%